Učitavanje...
Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer
Although cisplatin is one of the most effective antitumor drugs for ovarian cancer, the emergence of chemoresistance to cisplatin in over 80% of initially responsive patients is a major barrier to successful therapy. The precise mechanisms underlying the development of cisplatin resistance are not f...
Spremljeno u:
| Izdano u: | Korean J Physiol Pharmacol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746511/ https://ncbi.nlm.nih.gov/pubmed/29302211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.1.43 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|